Genius Sports Limited

Fundamentals6.0
Price Action5.0
News Sentiment5.0
AI Rating
4.0

Key Drivers

  • Strong liquidity
  • Persistent losses
  • Positive cashflow

AI
AI Summary

4.0

The investment case has shifted from a growth/monetization story to a capital-allocation and execution test—GENI's near-term value now hinges on whether management can convert commercial traction into consistent adjusted EBITDA and positive free cash flow without equity dilution while successfully integrating and financing the large Legend acquisition. Monitor consecutive quarters of improving cash conversion versus re‑set consensus and clear, measurable Legend synergies (no surprise earnouts or impairment) as the decisive catalysts for upside or further downside.

CapitalAllocation
IntegrationRisk
CashFlow‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • Strong liquidity
  • Persistent losses
  • Positive cashflow

GENI has a strong cash position and low leverage providing a solid runway, but persistent operating losses, negative returns and a large accumulated deficit threaten profitability recovery.

WeakProfitability
CashRunway

Price Behavior

5.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Downward momentum
  • Support holding nearby
  • Resistance intact

GENI is in a clear short-term downtrend—closing at $4.53 on 2026-03-20, about 26% below its 2026-02-20 level and trading well below the last month average (~$5.56), with immediate support at $4.53–$4.99 and resistance around $5.80–$6.50. ‌

weak
Support Level: $4.53–$4.99
Resistance Level: $5.80–$6.50

Prolonged drop from ~$10–$11 in

Sentiment & News

5.0

Key News Insights:

  • Record adjusted EBITDA
  • Q4 misses
  • New partnerships

Genius Sports reported 2025 revenue acceleration and record adjusted EBITDA but mixed Q4 results spurred analyst cuts and a 52-week low despite new commercial deals and integrations.

commercial
downgrade

Near-term share pressure is likely to continue as analysts trim forecasts, but recent commercial and tech deals bolster medium-term revenue and product traction